Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn

Cell Transplantation

Volumn 19, Issue 6-7, 2010, Pages 823-830

  Yagi, Hiroshi ^a   Soto Gutierrez, Alejandro ^a   Kitagawa, Yuko ^b   Tilles, Arno W ^a   Tompkins, Ronald G ^a   Yarmush, Martin L ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Anti inflammation; Antiapoptosis; Burn; Lipopolysaccharide (LPS); Multiple organ injury; Sepsis; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BURN; CELL DEATH; CELL FUNCTION; CELL INFILTRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE MODEL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MESENCHYME CELL; NICK END LABELING; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; RAT; STROMA CELL;

ANIMALS; BONE MARROW CELLS; BURNS; ENDOTOXEMIA; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MUSCLES; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; STROMAL CELLS;

ANIMALIA;

EID: 77958608856     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X508942     Document Type: Article

References (42)

1. Abbott, J. D.; Huang, Y.; Liu, D.; Hickey, R.; Krause, D. S.; Giordano, F. J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110(21): 3300-3305; 2004.
2. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4):1815-1822; 2005.
3. Alberti, C.; Brun-Buisson, C.; Goodman, S. V.; Guidici, D.; Granton, J.; Moreno, R.; Smithies, M.; Thomas, O.; Artigas, A.; Le Gall, J. R. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am. J. Respir. Crit. Care Med. 168(1):77-84; 2003.
4. Amann, B.; Luedemann, C.; Ratei, R.; Schmidt-Lucke, J. A. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant. 18(3):371-380; 2009.
5. Barthwal, M. K.; Sathyanarayana, P.; Kundu, C. N.; Rana, B.; Pradeep, A.; Sharma, C.; Woodgett, J. R.; Rana, A. Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J. Biol. Chem. 278(6):3897-3902; 2003.
6. Baue, A. E.; Durham, R.; Faist, E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? Shock 10(2):79-89; 1998.
7. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105(5): 2214-2219; 2005.
8. Brun-Buisson, C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 26(Suppl. 1): S64-74; 2000.
9. Buras, J. A.; Holzmann, B.; Sitkovsky, M. Animal models of sepsis: Setting the stage. Nat. Rev. Drug Discov. 4(10): 854-865; 2005.
10. Ciesla, D. J.; Moore, E. E.; Johnson, J. L.; Burch, J. M.; Cothren, C. C.; Sauaia, A. A 12-year prospective study of postinjury multiple organ failure: Has anything changed? Arch. Surg. 140(5):432-440; 2005.
11. Claridge, J. A.; Enelow, R. I.; Young, J. S. Hemorrhage and resuscitation induce delayed inflammation and pulmonary dysfunction in mice. J. Surg. Res. 92(2):206-213; 2000.
12. Deans, K. J.; Haley, M.; Natanson, C.; Eichacker, P. Q.; Minneci, P. C. Novel therapies for sepsis: A review. J. Trauma 58(4):867-874; 2005.
13. El-Achkar, T. M.; Huang, X.; Plotkin, Z.; Sandoval, R. M.; Rhodes, G. J.; Dagher, P. C. Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am. J. Physiol. Renal Physiol. 290(5):F1034-1043; 2006.
14. Estrada, E. J.; Valacchi, F.; Nicora, E.; Brieva, S.; Esteve, C.; Echevarria, L.; Froud, T.; Bernetti, K.; Cayetano, S. M.; Velazquez, O.; Alejandro, R.; Ricordi, C. Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplant. 17(12):1295-1304; 2008.
15. Garcia-Olmo, D.; Garcia-Arranz, M.; Herreros, D.; Pascual, I.; Peiro, C.; Rodriguez-Montes, J. A. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum 48(7):1416-1423; 2005.
16. Gnecchi, M.; He, H.; Liang, O. D.; Melo, L. G.; Morello, F.; Mu, H.; Noiseux, N.; Zhang, L.; Pratt, R. E.; Ingwall, J. S.; Dzau, V. J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11(4):367-368; 2005.
17. Gnecchi, M.; He, H.; Melo, L. G.; Noiseaux, N.; Morello, F.; de Boer, R. A.; Zhang, L.; Pratt, R. E.; Dzau, V. J.; Ingwall, J. S. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 27(4):971-979; 2009.
18. Gonzalez-Rey, E.; Anderson, P.; Gonzalez, M. A.; Rico, L.; Buscher, D.; Delgado, M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58(7):929-939; 2009.
19. Heidecke, C. D.; Hensler, T.; Weighardt, H.; Zantl, N.; Wagner, H.; Siewert, J. R.; Holzmann, B. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am. J. Surg. 178(4):288-292; 1999.
20. Heron, M. Deaths: Leading causes for 2004. Natl. Vital Stat. Rep. 56(5):1-95; 2007.
21. Huang, Y. S.; Yang, Z. C.; Liu, X. S.; Chen, F. M.; He, B. B.; Li, A.; Crowther, R. S. Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome (MODS) in severe burns. Burns 24(8): 706-716; 1998.
22. Jeschke, M. G.; Einspanier, R.; Klein, D.; Jauch, K. W. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol. Med. 8(8):443-450; 2002.
23. Jung, S. B.; Song, C. H.; Yang, C. S.; Kim, S. Y.; Lee, K. S.; Shin, A. R.; Lee, J. S.; Nam, H. S.; Kim, H. J.; Park, J. K.; Paik, T. H.; Jo, E. K. Role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in the secretion of tumor necrosis factor-alpha and interleukin-10 by the PPD antigen of Mycobacterium tuberculosis. J. Clin. Immunol. 25(5):482-490; 2005.
24. Kamimoto, M.; Mizuno, S.; Matsumoto, K.; Nakamura, T. Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase-1-dependent mechanism. Biochem. Biophys. Res. Commun. 380(2):333-337; 2009.
25. Kita, T.; Yamaguchi, H.; Sato, H.; Kasai, K.; Tanaka, T.; Tanaka, N. Role of p38 mitogen-activated protein kinase pathway on renal failure in the infant rat after burn injury. Shock 21(6):535-542; 2004.
26. Kyriakis, J. M.; App, H.; Zhang, X. F.; Banerjee, P.; Brautigan, D. L.; Rapp, U. R.; Avruch, J. Raf-1 activates MAP kinase-kinase Nature 358(6385):417-421; 1992.
27. Lange, C.; Togel, F.; Ittrich, H.; Clayton, F.; Nolte-Ernsting, C.; Zander, A. R.; Westenfelder, C. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 68(4):1613-1617; 2005.
28. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Gotherstrom, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363(9419): 1439-1441; 2004.
29. Lederer, J. A.; Rodrick, M. L.; Mannick, J. A. The effects of injury on the adaptive immune response. Shock 11(3): 153-159; 1999.
30. Meisel, R.; Zibert, A.; Laryea, M.; Gobel, U.; Daubener, W.; Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103(12): 4619-4621; 2004.
31. Nauta, A. J.; Kruisselbrink, A. B.; Lurvink, E.; Willemze, R.; Fibbe, W. E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte derived dendritic cells. J. Immunol. 177(4):2080-2087; 2006.
32. Nemeth, K.; Leelahavanichkul, A.; Yuen, P. S.; Mayer, B.; Parmelee, A.; Doi, K.; Robey, P. G.; Leelahavanichkul, K.; Koller, B. H.; Brown, J. M.; Hu, X.; Jelinek, I.; Star, R. A.; Mezey, E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15(1):42-49; 2009.
33. Oh, J. Y.; Kim, M. K.; Shin, M. S.; Wee, W. R.; Lee, J. H. Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells. Cytokine 46(1):100-103; 2009.
34. Ortiz, L. A.; Gambelli, F.; McBride, C.; Gaupp, D.; Baddoo, M.; Kaminski, N.; Phinney, D. G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100(14):8407-8411; 2003.
35. Parekkadan, B.; Tilles, A. W.; Yarmush, M. L. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26(7):1913-1919; 2008.
36. Parekkadan, B.; van Poll, D.; Megeed, Z.; Kobayashi, N.; Tilles, A. W.; Berthiaume, F.; Yarmush, M. L. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem. Biophys. Res. Commun. 363(2):247-252; 2007.
37. Parekkadan, B.; van Poll, D.; Suganuma, K.; Carter, E. A.; Berthiaume, F.; Tilles, A. W.; Yarmush, M. L. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2(9):e941; 2007.
38. Peter, F. W.; Schuschke, D. A.; Barker, J. H.; Fleishcher-Peter, B.; Pierangeli, S.; Vogt, P. M.; Steinau, H. U. The effect of severe burn injury on proinflammatory cytokines and leukocyte behavior: Its modulation with granulocyte colony-stimulating factor. Burns 25(6):477-486; 1999.
39. Rangel-Frausto, M. S.; Pittet, D.; Costigan, M.; Hwang, T.; Davis, C. S.; Wenzel, R. P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273(2):117-123; 1995.
40. Todorovic, Z.; Nesic, Z.; Stojanovic, R.; Basta-Jovanovic, G.; Radojevic-Skodric, S.; Velickovic, R.; Chatterjee, P. K.; Thiemermann, C.; Prostran, M. Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: It is never too late for the pretreatment. J. Pharmacol. Sci. 107(4):465-470; 2008.
41. van Poll, D.; Parekkadan, B.; Cho, C. H.; Berthiaume, F.; Nahmias, Y.; Tilles, A. W.; Yarmush, M. L. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47(5):1634-1643; 2008.
42. Yagi, H.; Parekkadan, B.; Suganuma, K.; Soto-Gutierrez, A.; Tompkins, R.; Tilles, A.; Yarmush, M. Long term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng. Part A 15(11):3377-3388; 2009.